Sponsors
Udskriv denne side
CSL Behring
CSL Behring is a global leader in the plasma protein biotherapeutics industry.

The company's broad portfolio of life-saving therapeutics are used in the treatment of individuals with haemophilia and other bleeding disorders, immune deficiency disorders and inherited emphysema; the prevention of haemolytic diseases for the newborn; cardiac surgery patients; and shock and burn victims.

Additionally, CSL Behring operates one of the world's largest, fully owned plasma collection networks.

CSL Behring is a subsidiary of CSL Limited, which operates worldwide from its headquarters in Melbourne, Australia.


Grifols
Grifols improves people's lives with high quality innovative hospital products and services. Our plasma-derived therapies have outstanding records of efficacy and safety and we are also a world-leading manufacturer of medical devices, analyzers and reagents used by blood banks, transfusion centers and clinical laboratories.


Linde
Linde Healthcare is dedicated to providing products, therapies and services to hospitals, patients, clinics, nursing facilities and emergency management services. Present in 70 countries around the world, we have established a solid foundation as the medical gas and clinical care specialist.


TEM International
Tem International provides patient diagnostic devices for acute bleeding. The ROTEM® system provides rapid results in whole blood. It gives an overview about the coagulation status after 10 minutes allowing controlled targeted therapies and avoiding unnecessary transfusion. Thus, it does not only save blood products, treatment costs and time, but also human lives.


Baxter
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.


Hamamatsu
Hamamatsu Photonics is a world leader in the manufacture of opto-electronic devices, including many for the medical market. The new NIRO-200NX Monitor enables the monitoring of the cerebral or systemic oxygenation. As it provides not only the oxygenation data but also can detect the haemodynamic functions in the tissue it is a perfect tool for monitoring and improvement of the patient management during cardiac surgery. Our NIRO monitors are routinely used in many hospitals.


Contacts EACTA 2012
Chairman EACTA 2012
Peter M.J. Rosseel
E-mail: Click here

Topics
  • I have a team!
  • What about safety?
  • Guidelines: blessing or evidence ?
  • New insights, new ideas
  • Anaemia and transfusion: the good, the bad and the ugly
  • Coagulation: puzzling factors
  • The microcirculation
  • Teamwork day: quality and people
  • Extracorporal circulation
  • Congenital cardiac surgery
  • Ultrasound pearls
  • Thoracic anaesthesia
  • The patient at cardiac risk undergoing vascular surgery
  • Society of Cardiovascular Anesthesiology panel
  • Teamwork debate